Status: Recruiting
Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
We investigate the role of empagliflozin in the treatment of obesity in PLWH.
Participants needed: 66
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Abdelrahman MahmoudUpdated: Jan 13, 2026Locations: 1
Eligibility criteria
Age >18 years up to 65 years old. [+5]
Diagnosis of Diabetes Mellitus, defined as a fasting blood glucose level > 126 m... [+8]